This clinical study aims to evaluate the efficacy of JAB-21822 in combination with cetuximab in patients with KRAS G12C-mutated colorectal cancer.
Sotatercept demonstrated significant improvement in exercise capacity and key secondary outcome measures compared to placebo when added to background therapy
Campaign to celebrate World Mental Health Day theme "Mental Health in an Unequal World"
Amantadine Extended-Release capsules had annual sales of US $2.7 million in the United States according to IQVIA data
Specialized cancer care will be offered to cancer patients making it accessible and affordable. We have adopted a patient-centric approach.
This will be an added advantage for Supriya Lifescience Limited in the European market.
Transformation to pure-play Innovative Medicines company nears completion
RYALTRIS is a fixed-dose combination therapy that provides relief for the symptoms of SAR, both nasal and ocular, in one easy-to-use nasal spray
One in two women with advanced ovarian cancer has an HRD-positive tumor
Our strategy to drive therapy and brand-focused expansion will continue to show results, especially in the domestic business.
Subscribe To Our Newsletter & Stay Updated
